MACKENZIE GEORGE: Open Payments
NPI 1750826061 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,710 in 81 payments from 19 companies in 2025. Trend: 2023 $1,892 · 2024 $3,027 · 2025 $2,710
Food & beverage: $1,820Consulting: $800Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $1,074 |
| Novartis Pharmaceuticals Corporation | 11 | $401 |
| E.R. Squibb & Sons, L.L.C. | 11 | $244 |
| Lilly USA, LLC | 10 | $208 |
| UCB, Inc. | 6 | $180 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
| Janssen Biotech, Inc. | 7 | $161 |
| BioWound Solutions, Inc. | 3 | $38 |
| Integra LifeSciences Corporation | 1 | $36 |
| LEO Pharma Inc. | 1 | $28 |
Products named: RINVOQ, COSENTYX, Sotyktu, DUPIXENT, Bimzelx, TREMFYA, TALTZ, SKYRIZI.
Industry payments across MT — which companies pay providers there.
